Quick fibrinogen test for trauma patients with heavy bleeding
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This trial checks if a fast bedside test for fibrinogen (a protein that helps blood clot) can help guide treatment for trauma patients who are actively bleeding. It may lead to better care in the emergency department.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 16 years or older and have had a serious injury
- You are still bleeding heavily right now
- A hospital trauma team has activated a massive transfusion protocol (meaning you need many blood products quickly)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests giving a blood clotting medicine called fibrinogen to adults with severe bleeding from trauma before they reach the hospital. The goal is to see if it helps control bleeding and improve outcomes.
This trial compares two types of blood tests (a new quick test vs. standard tests) to see which helps doctors better manage bleeding after a severe injury. It is for adults with serious trauma who may have a blood clotting problem.
This trial tests a standard set of emergency blood transfusions for people with life-threatening bleeding from a serious injury. It aims to improve survival by giving blood products quickly before reaching the hospital.
This study tests whether a drug called tranexamic acid (TXA) can help control bleeding in trauma patients. It uses a special blood test (thromboelastography) to monitor how well your blood clots during treatment.
This trial tests a personalized dose of fibrinogen, a protein that helps blood clot, for people having heart surgery with a heart-lung machine. The goal is to see if a tailored dose works better than a fixed dose after surgery.
This Phase 3 study tests whether giving fibrinogen early can improve outcomes for adults with serious trauma who are actively bleeding. The goal is to help blood clotting work better sooner and potentially reduce complications from uncontrolled bleeding.
Hear when a new Trauma Coagulopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.